These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24579682)

  • 1. Longitudinal evaluation of markers of hemostasis in pregnancy.
    Hammerova L; Chabada J; Drobny J; Batorova A
    Bratisl Lek Listy; 2014; 115(3):140-4. PubMed ID: 24579682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
    Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden mutation and its impact on pregnancy complications.
    Hammerová L; Chabada J; Drobný J; Bátorová A
    Acta Medica (Hradec Kralove); 2011; 54(3):117-21. PubMed ID: 22250481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis.
    Dudding TE; Attia J
    Thromb Haemost; 2004 Apr; 91(4):700-11. PubMed ID: 15045131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of factor V Leiden in maternal health and the outcome of pregnancy.
    Calderwood CJ; Greer IA
    Curr Drug Targets; 2005 Aug; 6(5):567-76. PubMed ID: 16026277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the factor V Leiden mutation on pregnancy.
    Spina V; Aleandri V; Morini F
    Hum Reprod Update; 2000; 6(3):301-6. PubMed ID: 10874575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
    Herman M; Djelmis J; Troselj Z; Ivanisević M
    Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications.
    Camilleri RS; Peebles D; Portmann C; Everington T; Cohen H
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):139-47. PubMed ID: 15091001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review.
    Alfirevic Z; Roberts D; Martlew V
    Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):6-14. PubMed ID: 11803092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombophilias and recurrent pregnancy loss.
    Kutteh WH; Triplett DA
    Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilia: implications for pregnancy outcome.
    Greer IA
    Thromb Res; 2003 Jan; 109(2-3):73-81. PubMed ID: 12706634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilia and adverse pregnancy outcome.
    Brenner B; Aharon A
    Clin Perinatol; 2007 Dec; 34(4):527-41, v. PubMed ID: 18063103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy and thrombophilia.
    Patnaik MM; Haddad T; Morton CT
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):753-65. PubMed ID: 17605653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombophilia in pregnancy--physiology and pathophysiology of hemocoagulation changes during normal and pathological gravidity].
    Sudrová M; Kvasnicka J; Linhartová P; Mazoch J
    Cas Lek Cesk; 2007; 146(11):853-7. PubMed ID: 18069211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome.
    Agorastos T; Karavida A; Lambropoulos A; Constantinidis T; Tzitzimikas S; Chrisafi S; Saravelos H; Vavilis D; Kotsis A; Bontis J
    J Matern Fetal Neonatal Med; 2002 Oct; 12(4):267-73. PubMed ID: 12572596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation.
    Nevalainen J; Ignatius J; Savolainen ER; Ryynanen M; Jarvenpaa J
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():32-35. PubMed ID: 30243226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin 20210 G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome.
    van Pampus MG; Wolf H; Koopman MM; van den Ende A; Buller HR; Reitsma PH
    Hypertens Pregnancy; 2001; 20(3):291-8. PubMed ID: 12044337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.